COVID-19 infection in primary central nervous system lymphoma treatment: Who is most at risk?
Br J Haematol
.
2022 Nov;199(4):480-481.
doi: 10.1111/bjh.18416.
Epub 2022 Aug 26.
Author
Sean H Lim
1
Affiliation
1
Centre for Cancer Immunology, University of Southampton, Southampton, UK.
PMID:
36017936
PMCID:
PMC9538935
DOI:
10.1111/bjh.18416
No abstract available
MeSH terms
COVID-19*
Central Nervous System / pathology
Central Nervous System Neoplasms* / pathology
Central Nervous System Neoplasms* / therapy
Humans
Lymphoma, Large B-Cell, Diffuse* / pathology
Grants and funding
27179/CRUK_/Cancer Research UK/United Kingdom